Burden, determinants and treatment status of metabolic syndrome among older adults in India: a nationally representative, community-based cross-sectional survey
Open Access
- 20 November 2023
- journal article
- Published by BMJ in BMJ Public Health
- Vol. 1 (1) , e000389
Abstract
Introduction Metabolic syndrome is a significance driver of mortality and morbidity in India, but nationally representative data regarding disease burden and treatment status are lacking. Here, a cross-sectional study was undertaken to establish national and regional estimates of disease burden and explore reasons for lack of treatment of component conditions of metabolic syndrome in Indian older adults (45 years and older). Methods A cross-sectional study was undertaken using data from the first wave of the Longitudinal Ageing Study in India (2017–2018). Data for 66 606 individuals aged 45 years and above were analysed. The primary outcome was metabolic syndrome prevalence, defined by the National Cholesterol Education Programme ATP III criteria as an individual having any three of four component conditions: diabetes mellitus (DM), hypertension, abdominal obesity and hypercholesterolaemia. The secondary outcome of this study was treatment status of patients with component conditions. Results Metabolic syndrome was found to have an overall weighted prevalence of 4.83% (n=3630, 95% CI 4.24 to 5.51). Females, urban residents, obese individuals and physically inactive people exhibited greater prevalence. The most prevalent component of metabolic syndrome was hypertension followed by abdominal obesity, DM and hypercholesterolaemia. 8.85% metabolic syndrome patient reported no treatment for component conditions, while 17.58% reported only partial treatment. Elderly individuals between 60 and 69 (crude relative risk ratios, cRRR 2.20, 95% CI 1.20 to 4.01) and 80 years and above (cRRR 7.48, 95% CI 1.99 to 28.16), urban residents (cRRR 2.45, 95% CI 1.48 to 4.05), those from richer monthly per capita consumption expenditure quintiles (cRRR 2.55, 95% CI 1.00 to 6.47) and those with additional comorbidities (cRRR 2.17, 95% CI 1.28 to 3.70) were more likely to report comprehensive treatment. Conclusions This study highlights a substantial prevalence of metabolic syndrome in older adults in India and reveals remarkable disparities in provision of treatment. Better prevention, earlier detection and improved provision of treatment are urgently required to combat the rising prevalence of metabolic syndrome and reduce the burden of cardiovascular disease in India.Keywords
This publication has 52 references indexed in Scilit:
- Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective StudiesPLOS ONE, 2012
- Prevalence of metabolic syndrome and gender differencesBioinformation, 2012
- Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern IndiaJournal of Cardiovascular Disease Research, 2012
- The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes MellitusJournal of the CardioMetabolic Syndrome, 2009
- The evolving definitions and increasing prevalence of the metabolic syndromeApplied Physiology, Nutrition, and Metabolism, 2007
- An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern ChinaPublic Health Nutrition, 2007
- South Asians and Cardiovascular RiskCirculation, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- The metabolic syndrome: prevalence in worldwide populationsEndocrinology and Metabolism Clinics of North America, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003